Back to first-pass browser

First-pass extracted concept

NLRP1 inflammasome

Candidate: concept label1 source documents7 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

NLRP1, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-1 inflammasome

Extracted Explainers

What the tool is doing

The review describes the NLRP1 inflammasome as a cytoplasmic inflammatory complex and the predominant inflammasome sensor in human keratinocytes. Its activation regulates IL-1β and IL-18 processing and can induce pyroptosis.

Source 1DOIPubMed

What problem it solves

As a review concept, it helps explain how diverse stressors and mutations can converge on inflammatory skin disease and skin cancer phenotypes.

Source 1DOIPubMed

What it does not solve

The abstract does not establish a specific engineered tool, assay workflow, or therapeutic intervention that directly solves NLRP1-driven disease.

Source 1DOIPubMed

Alternatives

The abstract notes that there are various types of inflammasome complexes, but does not name alternative inflammasome systems in detail.

Source 1DOIPubMed

Evidence Snippets

There are various types of inflammasome complexes, with the NLRP1 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-1) inflammasome being the first one identified and currently recognized as the predominant inflammasome sensor protein in human keratinocytes.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1activation triggersupports2023Source 1DOIPubMed

Human NLRP1 can be activated by viruses, ultraviolet B radiation, and ribotoxic stress responses.

Claim 2disease associationsupports2023Source 1DOIPubMed

Dysfunctions in the NLRP1 pathway have been implicated in vitiligo, psoriasis, atopic dermatitis, and skin cancer including squamous cell carcinoma, melanoma, and Kaposi sarcoma.

Claim 3disease associationsupports2023Source 1DOIPubMed

Emerging evidence implicates NLRP1 in systemic lupus erythematosus, pemphigus vulgaris, Addison disease, Papillon-Lefèvre syndrome, and leprosy.

Claim 4disease associationsupports2023Source 1DOIPubMed

Specific mutations in NLRP1 or related genes are associated with rare monogenic skin disorders including multiple self-healing palmoplantar carcinoma, familial keratosis lichenoides chronica, autoinflammation with arthritis and dyskeratosis, and dipeptidyl peptidase 9 deficiency.

Claim 5functional rolesupports2023Source 1DOIPubMed

Inflammasome activation directly regulates proteolytic processing and activation of IL-1β and IL-18 and induces pyroptosis.

Claim 6predominant cell type associationsupports2023Source 1DOIPubMed

NLRP1 is currently recognized as the predominant inflammasome sensor protein in human keratinocytes.

Claim 7therapeutic rationalesupports2023Source 1DOIPubMed

The review presents pathological dysregulation of the NLRP1 inflammasome as a pathway with potential rationale for future therapeutic targeting in skin disease.